91 related articles for article (PubMed ID: 2939952)
1. Risks for obesity.
Amodeo C; Messerli FH
Cardiol Clin; 1986 Feb; 4(1):75-80. PubMed ID: 2939952
[TBL] [Abstract][Full Text] [Related]
2. [Role of abdominal obesity in pathogenesis of insulin resistance syndrome].
Almazov VA; Blagosklonnaia IaV; Shliakhto EV; Krasil'nikova EI
Ter Arkh; 1999; 71(10):18-22. PubMed ID: 10612167
[TBL] [Abstract][Full Text] [Related]
3. [Long-term risks of polycystic ovaries syndrome].
Lefebvre P; Raingeard I; Renard E; Bringer J
Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116
[TBL] [Abstract][Full Text] [Related]
4. Risks for glucose intolerance.
Klaff LJ; Palmer JP
Cardiol Clin; 1986 Feb; 4(1):67-73. PubMed ID: 3518935
[TBL] [Abstract][Full Text] [Related]
5. [The cardiovascular risk factor in obesity].
Laufs U; Böhm M
Dtsch Med Wochenschr; 2000 Mar; 125(9):262-8. PubMed ID: 10742819
[No Abstract] [Full Text] [Related]
6. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
Srikanthan P; Korenman S; Davis S
Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
[TBL] [Abstract][Full Text] [Related]
7. Obesity and cardiovascular risk: the new public health problem of worldwide proportions.
Scaglione R; Argano C; Di Chiara T; Licata G
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):203-12. PubMed ID: 15151469
[TBL] [Abstract][Full Text] [Related]
8. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss.
Poirier P; Giles TD; Bray GA; Hong Y; Stern JS; Pi-Sunyer FX; Eckel RH
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):968-76. PubMed ID: 16627822
[TBL] [Abstract][Full Text] [Related]
9. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
10. Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?
Fleischmann EH; Bower JD; Salahudeen AK
Clin Nephrol; 2001 Sep; 56(3):221-30. PubMed ID: 11597037
[TBL] [Abstract][Full Text] [Related]
11. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines.
Mancini T; Kola B; Mantero F; Boscaro M; Arnaldi G
Clin Endocrinol (Oxf); 2004 Dec; 61(6):768-77. PubMed ID: 15579193
[TBL] [Abstract][Full Text] [Related]
12. Obesity and the risk of cardiovascular disease.
Björntorp P
Ann Clin Res; 1985; 17(1):3-9. PubMed ID: 3893310
[TBL] [Abstract][Full Text] [Related]
13. Preface: Chronic diseases in childhood obesity: risks and benefits of early intervention. Ohio, April 2-3, 2009.
Teich S; Michalsky MP
Semin Pediatr Surg; 2009 Aug; 18(3):125. PubMed ID: 19573753
[No Abstract] [Full Text] [Related]
14. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study.
Kelishadi R; Cook SR; Motlagh ME; Gouya MM; Ardalan G; Motaghian M; Majdzadeh R; Ramezani MA
J Am Diet Assoc; 2008 Jan; 108(1):82-90. PubMed ID: 18155992
[TBL] [Abstract][Full Text] [Related]
15. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
[TBL] [Abstract][Full Text] [Related]
16. [Hyperinsulinemia and cardiovascular risk].
Brunelli C; Spallarossa P; Cordera R; Caponnetto S
Cardiologia; 1994 Dec; 39(12 Suppl 1):163-8. PubMed ID: 7634261
[TBL] [Abstract][Full Text] [Related]
17. Risk-factor clustering and cardiovascular disease risk in hypertensive patients.
Weycker D; Nichols GA; O'Keeffe-Rosetti M; Edelsberg J; Khan ZM; Kaura S; Oster G
Am J Hypertens; 2007 Jun; 20(6):599-607. PubMed ID: 17531915
[TBL] [Abstract][Full Text] [Related]
18. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
[TBL] [Abstract][Full Text] [Related]
19. Clustering of silent cardiovascular risk factors in apparently healthy Hispanics.
Hoffmann IS; Cubeddu LX
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S137-41. PubMed ID: 11986912
[TBL] [Abstract][Full Text] [Related]
20. Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
de Simone G; Wachtell K; Palmieri V; Hille DA; Beevers G; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Julius S; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Devereux RB
Circulation; 2005 Apr; 111(15):1924-31. PubMed ID: 15837945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
